본문으로 건너뛰기
← 뒤로

SPHK1 Promotes Pancreatic Cancer Lymphangiogenesis Through the Activation of ERK in LECs.

1/5 보강
Molecular biotechnology 📖 저널 OA 6.3% 2022: 0/1 OA 2023: 1/1 OA 2024: 0/12 OA 2025: 2/16 OA 2026: 0/18 OA 2022~2026 2025 Vol.67(6) p. 2246-2253
Retraction 확인
출처

Yu M, Wang S, Zeng Y, Liu P, Li H

📝 환자 설명용 한 줄

Lymphatic metastasis is related to an unsatisfactory prognosis in pancreatic cancer.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Yu M, Wang S, et al. (2025). SPHK1 Promotes Pancreatic Cancer Lymphangiogenesis Through the Activation of ERK in LECs.. Molecular biotechnology, 67(6), 2246-2253. https://doi.org/10.1007/s12033-024-01192-9
MLA Yu M, et al.. "SPHK1 Promotes Pancreatic Cancer Lymphangiogenesis Through the Activation of ERK in LECs.." Molecular biotechnology, vol. 67, no. 6, 2025, pp. 2246-2253.
PMID 38861202 ↗

Abstract

Lymphatic metastasis is related to an unsatisfactory prognosis in pancreatic cancer. Sphingosine kinase 1 (SPHK1) is an oncogene in cancer. However, the potential effect of SPHK1 on the lymphangiogenesis of pancreatic cancer is little known. In this study, the expression level and role of SPHK1 in pancreatic cancer were evaluated to explore the underlying mechanism involved. The expression of SPHK1 and the lymphatic vessel density (LVD) in pancreatic cancer patient tissue were investigated by immunohistochemistry. The role of SPHK1 in lymphangiogenesis was verified in vitro. Elevated expression of SPHK1 was strongly related to high LVD in pancreatic cancer patient tissue. Silencing of SPHK1 in pancreatic cancer cells observably inhibited lymphangiogenesis. Furthermore, the downregulation of SPHK1 markedly attenuated the phosphorylation of extracellular signal-regulated kinase in lymphatic endothelial cells. This study revealed that SPHK1 might play a crucial role in pancreatic cancer lymphangiogenesis.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반